Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma × Sirolimus × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Myelodysplastic Syndromes 13 Lymphoma, Non-Hodgkin 13 Leukemia, Myeloid, Acute 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Mantle-Cell 12 Hodgkin Disease 12 Multiple Myeloma 10 Lymphoma 10 Leukemia 10 Sarcoma 9 Lymphoma, Large B-Cell, Diffuse 9 Graft vs Host Disease 9 Burkitt Lymphoma 9 Waldenstrom Macroglobulinemia 8 Myeloproliferative Disorders 8 Lymphoma, Follicular 8 Lymphoma, B-Cell, Marginal Zone 8 Tuberous Sclerosis 6 Primary Myelofibrosis 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Large-Cell, Immunoblastic 6 Leukemia, Myelomonocytic, Chronic 6 Congenital Abnormalities 6 Breast Neoplasms 6 Lymphoma, Large-Cell, Anaplastic 5 Lymphangioleiomyomatosis 5 Leukemia, Myeloid, Chronic-Phase 5 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5 Leukemia, Myeloid, Accelerated Phase 5

Interventions

Carboplatin 21 Cisplatin 14 pembrolizumab 12 Paclitaxel 12 Gemcitabine 12 Pemetrexed 9 130-nm albumin-bound paclitaxel 9 Everolimus 8 Cetuximab 6 durvalumab 5 Fluorouracil 5 Docetaxel 5 Cyclophosphamide 5 Axitinib 5 Albumin-Bound Paclitaxel 5 osimertinib 4 Sunitinib 4 Radiotherapy 4 Nivolumab 4 Ipilimumab 4 Erlotinib Hydrochloride 4 Sorafenib 3 Radiotherapy, Intensity-Modulated 3 Radiation 3 Octreotide 3 Irinotecan 3 Bevacizumab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 vosaroxin 2 pralsetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡